Amphetamine, past and present – a pharmacological and clinical perspective
David J. Heal(Nexor (United Kingdom)), David Nutt(Imperial College London), Jane Gosden(RenaSci (United Kingdom)), Sharon L. Smith(Unknown)
Cited by 614
Related Papers
The dopamine theory of addiction: 40 years of highs and lows
|Nature reviews. Neuroscience|2015|653
Estimating the Harms of Nicotine-Containing Products Using the MCDA Approach
|European Addiction Research|2014|442
Experimental Approaches to Anxiety and Depression
|Behavioural Pharmacology|1993|363
Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology
|Journal of Psychopharmacology|2014|284
Benzodiazepines: Risks and benefits. A reconsideration
|Journal of Psychopharmacology|2013|236